Related Experiment Videos
Inhibitory effect of prostaglandin E1 on human neutrophil function
K Mikawa1, H Akamatsu, N Maekawa
1Department of Anaesthesiology, Kobe University School of Medicine, Japan.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|October 1, 1994
Summary
Prostaglandin E1 (PGE1) reduces harmful neutrophil activity, including reactive oxygen species (ROS) production and cell movement, which may help treat conditions like acute respiratory distress syndrome (ARDS). This effect is linked to decreased intracellular calcium levels in neutrophils.
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Neutrophil accumulation in the lungs is implicated in host auto-injury, including ARDS.
- Understanding modulators of neutrophil function is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate the effects of prostaglandin E1 (PGE1) on key human neutrophil functions.
- To explore the mechanisms underlying PGE1's impact on neutrophil activity.
Main Methods:
- Assessed reactive oxygen species (ROS) generation in human neutrophils.
- Measured neutrophil phagocytosis and chemotaxis.
- Quantified intracellular calcium concentrations ([Ca2+]i) following stimulation.
Main Results:
- PGE1 significantly reduced ROS production, phagocytosis, and chemotaxis in neutrophils.
- PGE1 did not affect ROS generation in a cell-free system.
- PGE1 suppressed the f-Met-Leu-Phe-induced increase in intracellular calcium ([Ca2+]i) in neutrophils.
Conclusions:
- PGE1's inhibition of ROS production, phagocytosis, and chemotaxis may contribute to its therapeutic efficacy in host auto-injury, such as ARDS.
- Suppression of intracellular calcium ([Ca2+]i) increase appears to be a key mechanism for PGE1's inhibitory effects on neutrophil functions.